Changes in hospital mortality for United States intensive care unit admissions from 1988 to 2012

Over the last two decades there has been a decrease in mortality for patients admitted to US hospitals. Among Medicare patients who may or may not have been admitted to an ICU, risk adjusted mortality fell by 18% to 46% between 1994 and 2007 [1, 2]. Disease specific decreases in the 30-day mortality rate over time have also been reported for patients hospitalized for congestive heart failure (50%, 1993 to 2008) [3], community acquired pneumonia (28%, 1987 to 2005) [4] and surgery for subarachnoid hemorrhage (50%, 1980 to 2005)[5], coronary artery bypass graft (21%, 1999 to 2008) and other high-risk procedures [6]. Changes in hospital mortality have also been reported for US patients with disorders commonly managed in ICUs including sepsis (9.9%, 1979 to 2000) [7], acute lung injury (9%, 1996 to 2005) [8] and surgery for aortic dissection (17%, 1979 to 2003) [9].

To our knowledge temporal changes in hospital mortality have not been reported for patients admitted to US ICUs. In contrast, multi-institutional data have shown mortality reductions over time in Australia and New Zealand (4%, 1993 to 2003) [10] and England (13.4%, 1998 to 2006) [11]. Studies focused on ICU prognostic systems have also reported decreases in hospital mortality over the last two decades. These studies have repeatedly demonstrated 'model fade': the over prediction of mortality when risk adjustment models are applied to more recent data [12]. As a result, the Simplified Acute Physiology Score (SAPS) [13], Mortality Probability Model (MPM) [14], and Acute Physiology and Chronic Health Evaluation (APACHE) [15] have required repeated updating. The developers of these systems have attributed mortality over prediction to increased treatment effectiveness, improved care before ICU admission, and more frequent discharge to post-acute care facilities [13‐15].

Patients who are admitted to ICUs and survive hospitalization have a high mortality rate in the six months after discharge [16]. Many of these post-discharge deaths are among patients transferred to other acute-care hospitals [17] or long-term acute care facilities [18, 19]. These findings have raised concerns that hospital discharge practices may partially account for reductions in hospital mortality and adversely impact performance assessments that use predicted hospital mortality [17, 20].

This study reports a time series analysis of hospital mortality among patients admitted to multiple US ICUs over a 24-year period. The objectives of the study are: to describe changes in mortality and case-mix among ICU admissions from 1988 to 2012; to describe mortality changes among ICU patients with specific diagnoses over the same period; and to present data about the potential impact of patient discharge destination on hospital mortality. Data comparisons used a Chi-square test for categorical measures and an analysis-of-variance test for continuous measures.

We performed a retrospective analysis using data obtained from ICUs that had installed an APACHE system. Data for patients admitted before 2001 were obtained from published studies of APACHE. This emanated from two time periods: patient data for 1988 to 1989 were obtained from institutions randomly selected to represent US hospitals [21] and for 1993 to 1996 from a nonrandomized cohort of US institutions [22]. For admissions from 2001 onwards data were obtained for individual patients in the electronic APACHE database and grouped into three-year intervals. Multiple Institutional Review Boards (George Washington University, University of Maryland, Baystate Medical Center) waived the need for informed consent, deeming the use of these databases to not be human subject research requiring approval [15, 21‐24].

Patient data were generated as a result of patient care and collected for consecutive unselected ICU admissions. Demographic and clinical data were recorded on ICU day one, and vital status at ICU and hospital discharge. We did not collect data for patients with burns, ICU stay <4 hours, age <16 years and excluded second or subsequent ICU admissions. Further details about data collection, variables and the reliability of APACHE data have been described elsewhere [15, 21, 22].

The number of hospitals, ICUs and patients included in each data collection interval from May 1988 to June 2012 are shown in Table 1. The total number of ICU admissions was 482,601 and each time interval included ≥40 hospitals and ≥40 ICUs. With the exception of 1988 to 1989, all intervals contained at least 35,000 first admissions. The characteristics of the hospitals and ICUs are shown in Table 2. In general, hospital bed-size, teaching status, and geographic region were well dispersed, except for a smaller proportion of hospitals in the Northeast. The modal type of ICU was mixed medical-surgical, but most unit types were represented across the study.

The characteristics of patients admitted from 1988 to 2012 are shown in Table 3. For each cohort, patient age and severity of illness (APS) increased over time. There was a declining trend in the percentage of patients who were admitted post-operatively, from floors or by direct admission. Conversely, an increasing percentage of patients were admitted from another hospital or a step down unit. During the overall study period ICU length of stay decreased by 23% and hospital length of stay decreased by 38%.

In a clinical database from multiple US ICUs, we found that mortality at hospital discharge had a relative decrease of 35% (17.3% to 12.4%) from 1988/1989 to 2010/2012. This mortality reduction was accompanied by an increase in severity of illness and number of chronic health conditions, factors that typically pose an increase in mortality risk. There was also a >50% mortality reduction across ten diagnostic categories over the same 24-year interval. Most of these dramatic relative decreases in hospital mortality rate occurred between 1988 to 1989 and 1993 to 1996. To the best of our knowledge, this is the first longitudinal analysis of hospital mortality rates in a clinical (non-administrative) database for a large number of admissions to multiple US ICUs.

The decrease in hospital mortality was not uniform across diagnostic categories. This may be because medical advances are typically related to the development of new therapies for specific diseases. The dramatic reductions in our study are consistent with prior reports of improved mortality for patients with stroke [1, 2], acute myocardial infarction [1, 2], congestive heart failure [1, 3], chronic obstructive pulmonary disease [26] and sepsis [27]. Dramatic mortality reductions have also been reported after surgery for aortic dissection [9] and subarachnoid hemorrhage [28]. It is not our intention, however, to compare these disease specific mortality reductions with prior reports or relate them to new therapies.

Compared to reports from ICUs in other countries the changes in demographics and severity of illness were similar but reductions in hospital mortality were larger for these US ICU patients [10,11). Unfortunately, documented changes in the accuracy of APACHE mortality predictions over time [15, 22] precluded evaluation of the impact of case-mix on changes in observed versus predicted mortality rates between 1988 and 2012. Our study's retrospective design, differences in patient selection across time periods, lack of information about ICU structure, process and use of disease-specific treatments, also make it impossible to assess the reasons for and timing of these mortality decreases. We are, therefore, unable to comment on the impact of differing ICU types, staffing by critical care specialists, ventilator and sepsis bundles, and changes in disease-specific therapy on mortality.

We are unable to account for the impact of Medicare's prospective payment system in reducing mortality at hospital discharge. This legislation created a substantial shift in the time US patients spent in acute care hospitals to PAC facilities between 1984 and 2002 [25, 29]. These changes in discharge destination have previously been reported to shift hospital deaths to PACs [17, 20], long-term acute care facilities [17, 18] or other acute care hospitals [17, 19]. Because we lacked data about discharge destination before 2001 we are unable to assess the impact of discharge destination on the dramatic fall in mortality between 1988 to 1989 and 1993 to 1996. Reductions in mortality might also be related to the 1998 Joint Commission performance measurement requirements for patients with acute myocardial infarction, heart failure, and pneumonia and subsequent public reporting in 2004 [30].

The modest reduction in hospital mortality (10.5%) from 2001 to 2012 may have been influenced, at least in part, by the increasing frequency of discharge to PACs and other hospitals (Figure 6). It is also possible, however, that severely ill patients discharged home in 2001 to 2003 might be going to PACs in 2010 to 2012 and, thus, not confounding the reduction in mortality. This emphasizes the need to obtain long-term survival data to properly assess temporal changes in mortality for patients surviving to hospital discharge [16‐18].

The reduction in hospital mortality over this 24-year time interval explains why APACHE III (developed using 1988 to 1989 data) and APACHE IV (developed using 2002 to 2003 data) and other prognostic systems over predict mortality for contemporary ICU admissions. The over prediction of mortality is even greater for patients with specific diagnoses that had the largest mortality reductions between 1988/1989 and 2010/2012. The magnitude of these disease-specific changes may explain why recalibrating models that do not include specific diagnostic information often fails to improve calibration when tested in new populations [31‐33].

Our study is subject to several limitations. First, our data are not necessarily representative of all US ICUs because they were obtained only from units with an APACHE system. However, there was great diversity in hospital size, teaching status, region, as well as ICU type. Second, our data are subject to a selection bias because data from 1988 to 1989 and 1993 to 1996 were population based, whereas data from 2001 onwards was from a self-selected sample of ICUs. In addition, the data for this study were not serially collected from the same hospitals over the 24-year interval, and we cannot exclude the possibility that changes in outcome were related to ICU based differences in quality of care. Third, we lacked individual patient data for 1988 to 1989 and 1993 to 1996 admissions. For specific diagnostic groups, this hampered our ability to evaluate the impact of changes in severity of illness and other confounders on mortality. Finally, we did not have information about mortality after hospital discharge. For this reason we were unable to evaluate accurately the impact of changes in discharge destination on hospital mortality.

Hospital mortality for patients admitted to intensive care units has decreased significantly over the past quarter century despite an increase in the severity of patient illness. Decreases in mortality are diagnosis-specific and might be, in part, attributable to improvements in quality of care, but changing patterns in discharge destination and other confounders may also be responsible.

Hospital mortality for patients admitted to US intensive care units had a relative decrease of 35% between 1988 and 2012.

Reductions in hospital mortality were greater and more varied for patients within specific diagnostic groups.

Changes in hospital mortality over time explain why prognostic scoring systems over predict mortality when applied to more contemporary patient data.

Long-term outcome data are needed to assess the impact of discharge to post-acute care facilities on hospital mortality rates.